000 | 01155 a2200337 4500 | ||
---|---|---|---|
005 | 20250513091019.0 | ||
264 | 0 | _c19960716 | |
008 | 199607s 0 0 eng d | ||
022 | _a0921-4410 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCapranico, G | |
245 | 0 | 0 |
_aDNA topoisomerase inhibitors. _h[electronic resource] |
260 |
_bCancer chemotherapy and biological response modifiers _c1996 |
||
300 |
_a68-87 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aChromosome Aberrations _xchemically induced |
650 | 0 | 4 | _aChromosome Disorders |
650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xgenetics |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xenzymology |
650 | 0 | 4 | _aTopoisomerase I Inhibitors |
700 | 1 | _aGiaccone, G | |
700 | 1 | _aZunino, F | |
700 | 1 | _aGarattini, S | |
700 | 1 | _aD'Incalci, M | |
773 | 0 |
_tCancer chemotherapy and biological response modifiers _gvol. 16 _gp. 68-87 |
|
999 |
_c8638445 _d8638445 |